我們已在上線! 進一步了解
LMDXW

LumiraDx Limited Warrant

已下市

LMDXW已於2024年1月8日下市。

 

關於: LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.

員工: 1,210

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於LMDXW的最新新聞文章。

價格圖表採用Lightweight Charts™實作